No Data
Spero Therapeutics Faces SEC Probe and Leadership Changes
Spero Therapeutics Has Appointed Esther Rajavelu As Interim President And CEO, Stepping In For Sath Shukla, Who Has Agreed To A Voluntary Paid Administrative Leave For An Interim Period, The Board Has Also Appointed Director Frank Thomas As Chairman...
Express News | Spero Therapeutics Inc - Sath Shukla on Voluntary Paid Administrative Leave for Interim Period
Express News | Spero Therapeutics Inc - Cash Runway Guidance Remains Into Mid-2026
Express News | Spero Therapeutics Inc - Frank Thomas Appointed Chairman of the Board
Express News | Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes